At Gnosis by Lesaffre, we harness the power of microorganisms to transform compounds into usable nutritional actives, probiotics, and nutritional and functional yeasts that benefit human wellbeing. Our process is natural, is sustainable, and will shape the future of the industry. Our process is called biotransformation.
Can biotransformation help your company?
We relentlessly explore the potential of microbial biotransformation—an untapped, transformative resource—to develop natural, sustainable, and efficacious solutions for nutraceutical and pharmaceutical brands looking to develop game-changing products for consumers.
A partnership with Gnosis by Lesaffre is a step toward a better life for your customers
EXPLORING LIFE to IMPROVE
moving. digesting. aging. feeling. LIVING.
We collaborate with nutraceutical and pharmaceutical brands to develop game-changing products that help their customers thrive. We are true partners to our customers, supporting them with a portfolio of branded solutions, scientific guidance, clinical studies, and more.
We collaborate with dietary supplement, functional food and beverage, and pharmaceutical brands to develop game-changing products for their customers.
A natural source of vitamin K2 as MK-7 from biotransformation that supports healthy bones and cardiovascular system.
Fortifying with SAMe, vitamins, folate, and other ingredients to power your application.
Offering deactivated yeast strains that are packed with vitamins, minerals, proteins, and other nutritive ingredients.
Introducing living bacteria and yeasts to our bodies to provide health beneﬁts and restore microbiome.
Check here for the latest updates from Gnosis by Lesaffre.
A new infographic about Quality Consistency of Quatrefolic® explains why this is an integral aspect of our commitment to customers and partners and part of Quatrefolic® success.
Gnosis by Lesaffre proudly accepted the NIE Award for the Excipients/Non-actives/Delivery Systems category for its new Vitamin K2 Matrix protective technology, presented by Nutrition Industry Executive Editor-in-Chief Janet Poveromo.